Brief: Knight And Therapeuticsmd Announce Health Canada Approval Of Bijuva®
21/09/2020 22:03
Sept 21 (Reuters) - TherapeuticsMD Inc TXMD.O :
* KNIGHT AND THERAPEUTICSMD ANNOUNCE HEALTH CANADA APPROVAL
OF
BIJUVA®
* KNIGHT THERAPEUTICS - ANNOUNCED APPROVAL OF BIJUVA
(ESTRADIOL
AND PROGESTERONE) CAPSULES BY HEALTH CANADA
Source text for Eikon: ID:nBwbnzNjka
Further company coverage: TXMD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Knight Therapeutics
See all newsBrief: Knight Therapeutics Announces Regulatory Approval Of Niktimvo In Brazil
Brief: Knight Therapeutics - Launches Tavalisse In Brazil For Chronic Immune Thrombocytopenia
Brief: Knight Therapeutics Enters Into Exclusive Distribution Agreement With Kyowa Kirin International For Poteligeo® (Mogamulizumab)
Brief: Knight Therapeutics Announces Regulatory Approval Of Tavalisse® In Colombia
Brief: Knight Therapeutics Announces Supplemental Regulatory Submission For Minjuvi In Brazil